AIM
PLSE icon

Acrospire Investment Management’s Pulse Biosciences PLSE Stock Holding History

Acrospire Investment Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-222
Closed -$8K – 1064
2017
Q2 		$8K Sell
222
-479
-68% -$13.2K 0.01% 1863
2017
Q1 		$14K Buy
+701
New +$9.54K 0.01% 1776
2016
Q4 		– Sell
-400
Closed -$3K – 2373
2016
Q3 		$3K Buy
+400
New +$2.04K ﹤0.01% 1887

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HCS
Harvest Capital Strategies San Francisco, California $73.7M AUM 7.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TF
TIAA FSB Jacksonville, Florida $27.6B AUM 14.26% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Acrospire Investment Management's PLSE Position: Q3 2017 in Review

Acrospire Investment Management sold out of Pulse Biosciences (PLSE) in Q3 2017, closing a stake of 222 shares — an estimated $8K sold.

Acrospire Investment Management first reported a position in PLSE in Q3 2016 and held it in 3 quarters. The position peaked at $14K in Q1 2017. 43 funds tracked by Wall St. Rank hold PLSE as of Q3 2017.

  • Acrospire Investment Management reported no remaining Pulse Biosciences position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 222 Pulse Biosciences shares in Q3 2017, an estimated $8K.
  • Acrospire Investment Management first reported a position in Pulse Biosciences in Q3 2016 and held it in 3 quarters.
  • Acrospire Investment Management's Pulse Biosciences position peaked at $14K in Q1 2017.
  • 43 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.